X-PHY Inc Unveils Real-Time Deepfake Detection Tool Ahead of RSA Conference 2025
Expanding its AI-powered security suite, X-PHY takes aim at the rising threat of AI-generated deception SAN FRANCISCO, April 24, 2025 /PRNewswire/ — X-PHY... Read more.
Low-Cost ETFs and Long-Term Capital Funds Drive High-Dividend Strategies in A-Share Market
GUANGZHOU, China, April 24, 2025 /PRNewswire/ — In 2024, the A-share market achieved a historic milestone with total dividend payouts reaching RMB 2.4 trillion... Read more.
ACTO and ScienceMedia Partner to Enhance Clinical Competency and Confidence for Life Sciences Field Teams
AI-powered, on-demand access to clinical content enhances HCP interactions and drives measurable commercial impact for pharmaceutical companies. SAN DIEGO, April... Read more.
Locus Robotics Surpasses 5 Billion Pick Milestone, Accelerating Global Adoption of Mobile Warehouse Automation
Surging Demand for Mobile Warehouse Automation Fuels Unprecedented Growth and Global AMR Adoption WILMINGTON, Mass., April 24, 2025 /PRNewswire/ — Locus... Read more.
Invitation to presentation of the interim report January-March 2025 for Truecaller AB (publ)
STOCKHOLM, April 24, 2025 /PRNewswire/ — Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing... Read more.
Tuya Smart Unveils Four Core AIoT Technology Engines, Empowering Developers to Reconstruct the Physical World with AI
NEW YORK, April 24, 2025 /PRNewswire/ — On April 23, the 2025 TUYA Global Developer Summit officially opened in Shenzhen. Tuya Smart (NYSE: TUYA, HKEX: 2391),... Read more.
Super Seven: BingX Unveils $2.2M Anniversary Campaign With Games and Giveaways
PANAMA CITY, April 24, 2025 /PRNewswire/ — BingX, a global leading cryptocurrency exchange, is excited to launch its Super Seven anniversary celebration with... Read more.
AbolerIS Pharma Announces Formation of Scientific Advisory Board
GOSSELIES, Belgium and NANTES, France, April 24, 2025 /PRNewswire/ — AbolerIS Pharma (“AbolerIS”), a clinical-stage biopharmaceutical company committed... Read more.
XYRA Announces the Issuance of a Fifth New US Patent in a Series of Patents Which Protect the Use of Budiodarone in the Management of Atrial Fibrillation till after 2040
Budiodarone shown in Phase 2 to reduce atrial fibrillation symptoms and long episodes of atrial fibrillation (LEAF) FDA gives guidance on steps necessary to gain... Read more.
PQShield launches UltraPQ-Suite for deeply specialized implementations of post-quantum cryptography
PQShield’s UltraPQ-Suite allows companies across the global technology supply chain to adapt to new post-quantum cryptography (PQC) standards The products... Read more.